These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28755137)

  • 1. Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 µG Versus Twice-Daily Fluticasone Propionate 250 µG in Adolescents and Adults with Persistent Asthma.
    Tomlinson R; Parks D; Martin A
    Lung; 2017 Oct; 195(5):571-574. PubMed ID: 28755137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.
    Lötvall J; Bleecker ER; Busse WW; O'Byrne PM; Woodcock A; Kerwin EM; Stone S; Forth R; Jacques L; Bateman ED
    Respir Med; 2014 Jan; 108(1):41-9. PubMed ID: 24295556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
    O'Byrne PM; Jacques L; Goldfrad C; Kwon N; Perrio M; Yates LJ; Busse WW
    Respir Res; 2016 Nov; 17(1):157. PubMed ID: 27881132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
    Purucker ME; Rosebraugh CJ; Zhou F; Meyer RJ
    Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
    Pearlman DS; LaForce CF; Kaiser K
    Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
    Kerwin EM; Gillespie M; Song S; Steinfeld J
    J Asthma; 2017 Jan; 54(1):89-98. PubMed ID: 27285965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
    Beeh KM; Derom E; Echave-Sustaeta J; Grönke L; Hamilton A; Zhai D; Bjermer L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():193-205. PubMed ID: 26893551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma.
    Boulet LP; Cowie RL; Negro RD; Brett W; Gold M; Marques A; Thorburn WS; Stepner NM; Robson R
    Can Respir J; 2000; 7(3):239-47. PubMed ID: 10903487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study.
    Lee LA; Yang S; Kerwin E; Trivedi R; Edwards LD; Pascoe S
    Respir Med; 2015 Jan; 109(1):54-62. PubMed ID: 25452139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.